Cosmos Healthcare’s revolutionary approach successfully applied to over 4,000 Children with autism.
September 26, 2024– Cosmos Healthcare, led by renowned specialist neuropsychologist Dr. Alptekin Aydin, has introduced the QPAN® model, a cutting-edge approach to unlocking potential for autism and other neurodevelopmental disorders. Since its development in 2018, the QPAN® model has successfully applied to more than 4,000 children, delivering promising results in improving cognitive and behavioral functions.
The QPAN® Model: A Personalized Approach to Neuro-Rehabilitation and Beyond
QPAN® combines advanced technologies, including QEEG (quantitative electroencephalography) brain scans and AI-driven neuromodulation protocols with Neuromap® harnesses the power of AI to transform EEG data into cutting-edge QEEG reports, offering unparalleled insights into brain function, to create personalized treatment plans for each individual. These treatment plans are further enhanced by incorporating therapy, education, sports, and nutrition programs, all tailored to address each individual’s unique neurological and physiological needs.
Dr. Aydin explains, “QPAN® is designed to identify and address brain function abnormalities using precise data-driven methods. Our model integrates AI technology with traditional therapies, ensuring that each child receives the care they need to thrive.”
Key Features of the QPAN® Model
- QEEG Brain Scan Technology: QEEG scans provide detailed brain activity mapping, helping pinpoint areas of dysfunction. This FDA-approved and CE-marked diagnostic tool offers a personalized diagnosis by comparing brainwave patterns to normative databases.
- AI-Driven Brain Function Mapping via Neuromap®: Advanced AI algorithms analyze the QEEG data, creating a comprehensive brain map that highlights both strengths and weaknesses. This information is used to develop a customized nutritional, educational, rehabilitation & treatment plans.
- Comprehensive Neuromodulation Protocols: The QPAN® model utilizes non-invasive techniques such as Transcranial Direct Current Stimulation (tDCS), which enhances cognitive function and mood regulation. This CE-approved method has been shown to improve cognitive tasks like memory and problem-solving.
Impact and Success of QPAN®
Since its inception, the QPAN® model has achieved a remarkable success rate, demonstrating its effectiveness in improving cognitive functions and overall well-being. The holistic approach ensures that each child receives a comprehensive and customized treatment plan.
“QPAN® has transformed how we approach neurodevelopmental disorders,” Dr. Aydin noted. “Our goal is not just to manage symptoms, but to provide long-lasting improvements in quality of life for children with autism and their families.”
Future Expansion and Research
Cosmos Healthcare is committed to expanding the reach of the QPAN® model. With plans to introduce the model to clinics and hospitals worldwide, Dr. Aydin and his team continue to invest in research and development, ensuring the integration of the latest scientific advancements in neuro-rehabilitation.
For more information about QPAN® and its groundbreaking approach to autism treatment, please visit www.cosmoshealth.co.uk.
Media Contact
Name: Dr. ALPTEKIN AYDIN (Specialist Neuropsychologist)
Clinic Address: 33 London Road, Cosmos Healthcare, Redwood House, Enfield, EN2 6DR
Telephone: 020 8243 8590, 020 8144 9884
Email: info@cosmoshealth.co.uk
Website: www.cosmoshealth.co.uk
####
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No EU Brief journalist was involved in the writing and production of this article.